Glycaemic control and excess mortality in patients with type 2 diabetes

被引:0
|
作者
Tancredi, M. [1 ]
Rosengren, A. [2 ]
Svensson, A. -M. [3 ]
Kosiborod, M. [4 ]
Pivodic, A. [5 ]
Gudbjornsdottir, S. [2 ]
Dahlqvist, S. [6 ]
Wedel, H. [7 ]
Lind, M. [8 ]
机构
[1] NU Hosp Org, Med, Trollhattan, Sweden
[2] Univ Gothenburg, Med, Gothenburg, Sweden
[3] Registercentrum, Gothenburg, Sweden
[4] Univ Missouri, Heart Inst, Columbia, MO 65211 USA
[5] Stat Konsultgrp, Gothenburg, Sweden
[6] NU Hosp Org, Uddevalla, Sweden
[7] Nord Sch Publ Hlth, Gothenburg, Sweden
[8] NU Hosp Org, Med, Uddevalla, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
271
引用
收藏
页码:S137 / S137
页数:1
相关论文
共 50 条
  • [1] Glycaemic control, cardiovascular disease, and mortality in type 2 diabetes
    Chiasson, Jean-Louis
    Le Lorier, Jacques
    LANCET, 2014, 384 (9958): : 1906 - 1907
  • [2] Association of tight glycaemic control with nine-year mortality in type 2 diabetes patients
    Strele, I.
    Rozite, S.
    Brigis, G.
    Pirags, V.
    DIABETOLOGIA, 2010, 53 : S66 - S67
  • [3] Factors associated to glycaemic control in patients with type 2 diabetes
    Panarotto, Daniel
    Teles, Alisson Roberto
    Schumacher, Marina Verdi
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2008, 54 (04): : 314 - 321
  • [4] The Effects of Depression on Glycaemic Control in Patients with Type 2 Diabetes
    Zhu, Jasmine J.
    Hare, David L.
    Jerums, George
    Stewart, Andrew G.
    Macisaac, Richard J.
    DIABETES, 2014, 63 : A592 - A592
  • [5] Poor glycaemic control is related to excess risks of hospitalisation for infection in patients with type 2 diabetes: the Hong Kong Diabetes Registry
    Luk, A. O. Y.
    Lau, E. S. H.
    Cheung, K. K. T.
    Kong, A. P. S.
    Ma, R. C. W.
    Ozaki, R.
    Chow, F. C. C.
    So, W. Y.
    Chan, J. C. N.
    DIABETOLOGIA, 2016, 59 : S510 - S510
  • [6] Excess foetal growth and glycaemic control in type 1 diabetes and pregnancy
    Ring, S.
    Glastras, S. J.
    Hocking, S. L.
    Seeho, S. K.
    Scott, E. S.
    Fulcher, G. R.
    McGrath, R. T.
    DIABETES & METABOLISM, 2019, 45 (05) : 497 - 499
  • [7] Glycaemic control and excess risk of major coronary events in patients with type 2 diabetes: a population-based study
    Tancredi, Mauro
    Rosengren, Annika
    Svensson, Ann-Marie
    Pivodic, Aldina
    Gudbjornsdottir, Soffia
    Wedel, Hans
    Lind, Marcus
    OPEN HEART, 2019, 6 (02):
  • [8] Sitagliptin Monotherapy improved glycaemic control in patients with type 2 diabetes
    Aschner, P.
    Kipnes, M.
    Lunceford, J.
    Sanchez, M.
    Mickel, C.
    Davies, M. J.
    Williams-Herman, D.
    DIABETOLOGIA, 2006, 49 : 5 - 5
  • [9] Lixisenatide in patients with type 2 diabetes and obesity: Beyond glycaemic control
    Mar Roca-Rodriguez, M.
    Muros de Fuentes, Maria Teresa
    Piedrola-Maroto, Gonzalo
    Quesada-Charneco, Miguel
    Maraver-Selfa, Silvia
    Tinahones, Francisco J.
    Mancha-Doblas, Isabel
    ATENCION PRIMARIA, 2017, 49 (05): : 294 - 299
  • [10] Dimethylarginines in patients with type 2 diabetes mellitus: Relation with the glycaemic control
    Can, Ayten
    Bekpinar, Seldag
    Gurdol, Figen
    Tutuncu, Yildiz
    Unlucerci, Yesim
    Dinccag, Nevin
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (03) : E61 - E64